Study Reveals Racial and Ethnic Differences in How Chronic Conditions Contribute to Mortality
A new study uncovers how the impact of chronic diseases on mortality varies across different racial and ethnic groups, highlighting disparities and the need for targeted healthcare interventions.
Recent research has shed light on how chronic health conditions influence mortality differently across racial and ethnic groups in the United States. Led by Dr. Heather Allore from Yale School of Medicine, a comprehensive study analyzed data from over 10,000 participants in the Health and Retirement Study, spanning from 1998 to 2020. The investigation focused on the prevalence and incidence of various chronic diseases, including heart disease, stroke, diabetes, lung disease, cancer, depression, and dementia, and examined their association with mortality.
The findings revealed significant variations in how different conditions contribute to death within diverse groups. Overall, long-term chronic conditions were responsible for 58% to 74% of deaths among Hispanic, Black, and white U.S.-born adults. Notably, the primary contributors to mortality differed among these groups. For white adults, heart disease, cancer, hypertension, and pulmonary conditions were the leading causes. Conversely, among Hispanic and Black adults, hypertension, heart disease, diabetes, and dementia played a more prominent role.
These disparities underscore the importance of developing targeted healthcare strategies that address the specific needs of diverse populations. Improving access to preventive care and effective treatments can potentially reduce mortality rates linked to these conditions.
Dr. Allore emphasized that advancing patient-centered healthcare models is crucial in managing chronic diseases effectively. Such initiatives aim to enhance the quality of care, delay the onset of multiple health conditions, and prevent fatal outcomes.
This research highlights the necessity for health systems to prioritize tailored interventions that address the unique risk profiles of different racial and ethnic groups, ultimately contributing to better health outcomes and reduced disparities.
Source: Medical Xpress
Note: The study is published in Aging and Health Research, 2025.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Diabetic Neuropathy: The Role of Nageotte Nodules and Sensory Cell Degeneration
New research highlights the significance of Nageotte nodules—clusters of dead neurons—in the progression of diabetic neuropathy. These findings could lead to novel neuroprotective treatments targeting nerve degeneration in diabetes-related pain.
FDA Approves Ajovy for Migraine Prevention in Children and Adolescents
The FDA has approved Ajovy, a CGRP antagonist, for preventing episodic migraines in children and adolescents aged 6 to 17, offering a new targeted treatment option for young patients. that can help reduce migraine attacks and improve quality of life.
Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs
New research shows that youthful immune cells derived from stem cells can reverse signs of brain aging and improve memory in mouse models, promising potential therapies for neurodegenerative diseases.
Importance of Continued Mammogram Screenings After 75: New Research Indicates Potential Life-Saving Benefits
Recent research shows that continued mammogram screenings after age 75 can lead to earlier detection of breast cancer and potentially save lives. Personalized decisions are recommended.